Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Truist Financial analyst Joon Lee maintains $Praxis Precision Medicines(PRAX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 23

moomoo NewsJun 13 07:32 ET · Ratings

Express News | Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ReutersJun 4 17:00 ET

10 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan

BenzingaMay 31 13:35 ET

This Is Why Praxis Precision Medicines, Inc.'s (NASDAQ:PRAX) CEO Compensation Looks Appropriate

Yahoo FinanceMay 30 06:26 ET

Express News | Praxis Precision Medicines Inc : Jefferies Raises Target Price to $141 From $128

ReutersMay 28 03:37 ET

Praxis Precision Medicines (NASDAQ:PRAX): A Wild Rollercoaster Ride

TipRanksMay 22 03:58 ET